Current Trials
Our clinical trials complement observational studies to further validate patient experiences during treatment with our NanoCelle® products.
Current Products
Learn about our NanoCelle® THC/CBD and CBD products that are currently available via the TGA Special Access Scheme in Australia.
Product Pipeline
Our robust clinical trial and observational study programs continue to demonstrate the power of NanoCelle® to deliver safer and more effective treatment outcomes.
Our Mission and Values
Together we can overcome the biggest health concerns of our time and change the course of medicine.